21 CFR Part 211 Implementation Documents

Ensure regulatory compliance, product quality, and data integrity with our 21 CFR Part 211 Audit Checklist—a complete, professionally developed, and fully customizable tool designed for pharmaceutical manufacturers to meet U.S. FDA current Good Manufacturing Practice (cGMP) requirements for finished drug products.

This ready-to-use checklist provides a structured approach for internal audits, third-party inspections, and FDA preparedness.

What’s Included:

21 CFR Part 211 Clause-wise Audit Checklists

Detailed, section-by-section checklists covering all key areas of drug product manufacturing including organization and personnel, buildings and facilities, equipment, production and process controls, holding and distribution, laboratory controls, records, and packaging.

Editable Format

Provided in Word and Excel formats, fully editable to suit your organization’s processes, site structure, or product categories.

Observation & Evidence Fields

Dedicated space to record observations, evidence reviewed, audit findings, nonconformities, and corrective action references.

Risk Rating Section

Built-in fields to assign criticality levels to each non-compliance or observation, aiding prioritization and corrective planning.

Follow-up and Closure Tracking

Includes tracking sections to monitor the status of corrective actions and ensure timely closure.

Key Benefits:

• Aligns with the exact requirements of 21 CFR Part 211 for finished pharmaceuticals
• Supports internal cGMP audits, mock FDA audits, and supplier assessments
• Helps identify compliance gaps and supports continuous improvement
• Saves time and ensures thorough, repeatable inspections across teams
• Suitable for quality assurance teams, compliance officers, and consultants
• 
  

Get your 21 CFR Part 211 Audit Checklist today and strengthen your organization’s readiness for FDA inspections and regulatory compliance.